DELINDA KAYROUZ: Open Payments
NPI 1669256863 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,191 in 47 payments from 16 companies in 2025. Trend: 2023 $18 · 2024 $1,649 · 2025 $1,191
Food & beverage: $1,191
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $387 |
| Novo Nordisk Inc | 8 | $228 |
| Lilly USA, LLC | 11 | $168 |
| ABBVIE INC. | 9 | $157 |
| PFIZER INC. | 2 | $37 |
| SHIELD THERAPEUTICS INC | 2 | $31 |
| Exact Sciences Corporation | 2 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Abbott Laboratories | 1 | $18 |
Products named: BREZTRI, AIRSUPRA, Ozempic, UBRELVY, MOUNJARO, JARDIANCE, QULIPTA, Wegovy.
Industry payments across KY — which companies pay providers there.
